EUCTR2019-000585-38-GB进行中（未招募）1 期
Chronic Endometritis and Recurrent Miscarriage - The CERM trial - The CERM Trial
niversity Hospitals Coventry and Warwickshire NHS Trust0 个研究点目标入组 3,062 人开始时间: 2020年10月8日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 3,062
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Inclusion criteria - screening
- •Age =18 to <42
- •Two or more consecutive first trimester intrauterine miscarriages (=14 weeks gestation).
- •Women who agree to use barrier methods of contraception during the following cycles: biopsy preparation, screening-biopsy, waiting for the results and during the intervention.
- •Inclusion criteria - RCT
- •Women with =5 CD138+ cells/10mm2.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1500
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Exclusion criteria – screening
- •Treatable cause(s) of RM for example:
- •oantiphospholipid antibody syndrome
- •othyroid disease
- •oparental karyotypical abnormalities.
- •Known sub-septate uterus.
- •Poorly controlled diabetes (HbA1c >48mmol/mol)
- •Allergy to doxycycline or its excipients.
- •Doxycycline contraindicated
- •Antibiotics in the current menstrual cycle
- •Taking a medication that may interact with doxycycline
- •Myasthenia Gravis.
- •Systemic lupus erythematosus (SLE).
- •Immunodeficiency disorder.
- •Alcohol dependency*
- •Long-term antibiotic(s) use.
- •Menstrual cycle =21 - =42 days.
- •Unable to give informed consent.
- •Participation in another clinical trial of an investigational medicinal product (CTIMP) within the last 90 days.
- •Women who are breast feeding.
- •Exclusion criteria – RCT
- •A course of antibiotics between screening registration and randomisation to RCT**
- •A delay of longer than three months between biopsy result and randomisation to RCT**
- •Known serious liver disease*1
- •Taking a medication that may interact with doxycycline
- •Any co-morbid disease or condition that would make the patient unsuitable for the trial*1
- •*As judged by a medically qualified doctor assessing trial eligibility informed by referral letter from GP and hospital records
- •**If a woman has a course of antibiotics between screening registration and randomisation or was registered for screening over three months before randomisation to the RCT they will not be eligible for trial randomisation at the time. These women should be given the option to re-screen and have another biopsy to confirm eligibility for randomisation.
- •1If a clinician has doubts about a participants’ suitability for the trial because of a long-term medical condition they should undertake a Full Blood Count (FBC) and Liver function tests (LFTs); in order for a woman to be included in the trial the following should apply:
- •WBC >3x10^9/L,
- •Neutrophils >1.5x10^9/L,
- •Platelets >75x10^9/L, Hb>100g/L
- •Bilirubin <1.5XULN*
- •AST/ALT <3xULN*
- •Albumin >30g/dL).
- •* ULN = Upper Limit of Normal
- •All required additional checks must be documented in the patients’ medical notes
研究者
相似试验
已完成
2 期
The effect of doxycycline on live birth rates in women with chronic endometritis suffering from recurrent miscarriageRecurrent miscarriagePregnancy and ChildbirthHabitual aborterISRCTN23947730niversity Hospitals Coventry and Warwickshire NHS Trust737
已完成
不适用
Relation between chronic endometritis and recurrent miscarriageACTRN12618000561280Department of Obstetrics and Gynecology, Ahmadi hospital, Kuwait.110
招募中
不适用
Impact of chronic endometritis in endometrial receptivity and the prediction of the personalized window of implantation: a prospective before-and-after studyInfertilityJPRN-UMIN000046909Igenomix Foundation240
已完成
不适用
Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro FertilizationAbortion, SpontaneousInfertilityEndometritisNCT01762098Clinique Ovo100
终止
不适用
Diagnosis of Chronic Endometritis in Endometrial Fluid Using Molecular Techniques to Improve the Outcomes of Assisted Reproductive TreatmentsChronic EndometritisNCT03169621Igenomix5